Articles

Researchers conducted a study on 145 patients with night vision problems, testing the effects of 0.75% phentolamine ophthalmic solution

There's much to do and see in San Francisco, where the American Academy of Ophthalmology (AAO) 2023 annual meeting will run from Friday 3 November through Monday 6 November

Data from the study, presented at the 2023 American Academy of Ophthalmology meeting in San Francisco, support the implantation of the LAL in eyes that had undergone a previous RK

Study results indicated low-light therapy can help prevent dry eye disease following cataract surgery

No two corneal ulcers are alike, but if they are large and centrally located, the common denominator is that time is of the essence

Surgeons can save space and optimise workflow efficiency in the operating room

The collection at the Truhlsen-Marmor Museum of the Eye includes more than 38,000 objects, including rare books, instruments and immersive educational materials.

According to Genentech, RVO is the third indication for Vabysmo, in addition to wet, or neovascular, age-related macular degeneration and diabetic macular oedema

The patent is also being prosecuted in the European Union and around the globe

For clinicians, the evolution of treatment is as much a responsibility as an opportunity

Several companies including Kiora Pharmaceuticals, Adverum Biotechnologies and Aviceda Therapeutics, will share data at the 2023 meeting in San Francisco, California

AffaMed Technologies is the joint venture between AffaMed Therapeutics and SIFI

Mutations in the EMC1 gene appear to be associated with familial exudative vitreoretinopathy (FEVR), a severe ocular condition.

The price tag of publishing presents a tricky research barrier

Data indicated switching to SB15 from AFL maintained comparable clinical efficacy and safety, confirming biosimilarity between these agents

Academy’s program will take place in San Francisco, California, 3-6 November 2023, before returning to Chicago, Illinois in 2024

Investigators emphasised a significant unmet need for home-based monitoring of visual function with patient-centric technologies

Case 1 highlights the potential for this treatment for patients with dry AMD with noted letter gains

The findings showed significant correlations between positive bacterial cultures and severe ROP, which requires diode laser and anti-VEGF treatment

The 23rd annual EURETINA Congress took place in Amsterdam, the Netherlands. We spoke with Arshad M. Khanani, MD, MA, FASRS, who provided an overview of his presentation, "Emerging therapies for exudative AMD"

ARCATUS, also known as XIPERE®, utilises a revolutionary suprachoroidal delivery platform, offering new hope to patients in China suffering from this vision-threatening condition

Robyn Guymer, MBBS, PhD, Deputy Director, Centre for Eye Research Australia, and Professor of Surgery (Ophthalmology), University of Melbourne, Australia, discussed the study findings at the 23rd annual EURETINA Congress in Amsterdam, the Netherlands

We spoke with Michael Singer, MD who provided an overview of his presentation, "MCO-010 Optogenetic Therapy to Treat Stargardt Disease: Safety and Efficacy through Week 48 in the Phase 2a STARLIGHT Clinical Trial"

Dr Ali Erginay of Lariboisière Hospital in Paris, France, discusses his EURETINA presentation, "Introducing optomap® Ultra-widefield Colour Red-Green-Blue Multimodal Imaging"

Our team spoke to David Almeida, MD, PhD, MBA about his EURETINA presentation titled, The Real-World Efficacy and Safety of Faricimab in Neovascular AMD: The TRUCKEE Study.

Our team spoke to Varun Chaudhary, MD, about his EURETINA presentation, titled "Systematic Review and Metanalysis in Macular Hole RCTs – Posturing after Macular Hole Surgery"

For retinal specialists grappling with diseases once thought “untreatable,” gene therapies present a wide range of viable options

The new range of pure and premixed gases are intended for medium-term use in retinal surgery

Laser scleral microporation rejuvenates dynamic range of focus by increasing scleral pliability, allowing underlying structures to move more freely

Results showed that the PAUL Glaucoma Implant is an effective glaucoma drainage device that provides effective IOP lowering, similar to that achieved with the Baerveldt Glaucoma Implant, but with lower rates of complications